ANSELMI, MARTINA
ANSELMI, MARTINA
Impact of in vitro SARS-CoV-2 infection on breast cancer cells
2024 M. Sommariva, M. Dolci, T. Triulzi, F. Ambrogi, M. Dugo, L. De Cecco, V. Le Noci, G. Bernardo, M. Anselmi, E. Montanari, S.M. Pupa, L. Signorini, N. Gagliano, L. Sfondrini, S. Delbue, E. Tagliabue
Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures
2024 F. Fontana, M. Sommariva, M. Anselmi, F. Bianchi, P. Limonta, N. Gagliano
Adipocytes reprogram prostate cancer stem cell machinery
2023 F. Fontana, M. Anselmi, P. Limonta
Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer
2023 F. Fontana, M. Anselmi, P. Limonta
PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma
2023 F. Fontana, C. Macchi, M. Anselmi, A.S. Rizzuto, M. Ruscica, P. Limonta
Adipocyte-Derived Extracellular Vesicles Promote Prostate Cancer Cell Aggressiveness by Enabling Multiple Phenotypic and Metabolic Changes
2022 F. Fontana, M. Anselmi, E. Carollo, P. Sartori, P. Procacci, D. Carter, P. Limonta
Melanoma Stem Cells Educate Neutrophils to Support Cancer Progression
2022 M. Anselmi, F. Fontana, M. Marzagalli, N. Gagliano, M. Sommariva, P. Limonta
Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol
2022 F. Fontana, M. Anselmi, P. Limonta
Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression
2022 F. Fontana, M. Anselmi, P. Limonta
Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy
2022 F. Fontana, M. Anselmi, P. Limonta